Your browser doesn't support javascript.
loading
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
Rick, Ferenc G; Abi-Chaker, Andrew; Szalontay, Luca; Perez, Roberto; Jaszberenyi, Miklos; Jayakumar, Arumugam R; Shamaladevi, Nagarajarao; Szepeshazi, Karoly; Vidaurre, Irving; Halmos, Gabor; Krishan, Awtar; Block, Norman L; Schally, Andrew V.
Affiliation
  • Rick FG; Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, FL 33125, USA. ferencrick@gmail.com
Proc Natl Acad Sci U S A ; 110(7): 2617-22, 2013 Feb 12.
Article in En | MEDLINE | ID: mdl-23359692
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Prostate / Prostatic Hyperplasia / Bombesin / Gastrin-Releasing Peptide / Cell Size Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Proc Natl Acad Sci U S A Year: 2013 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Prostate / Prostatic Hyperplasia / Bombesin / Gastrin-Releasing Peptide / Cell Size Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Proc Natl Acad Sci U S A Year: 2013 Type: Article Affiliation country: United States